A detailed history of Geode Capital Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 323,908 shares of BIO stock, worth $108 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
323,908
Previous 478,838 32.36%
Holding current value
$108 Million
Previous $131 Million 17.13%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$263.97 - $344.64 $40.9 Million - $53.4 Million
-154,930 Reduced 32.36%
323,908 $108 Million
Q2 2024

Aug 09, 2024

BUY
$268.26 - $339.48 $1.51 Million - $1.91 Million
5,637 Added 1.19%
478,838 $131 Million
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $3.99 Million - $4.62 Million
13,115 Added 2.85%
473,201 $164 Million
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $2.15 Million - $2.91 Million
7,984 Added 1.77%
460,086 $149 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $483,695 - $583,652
1,381 Added 0.31%
452,102 $162 Million
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $2.09 Million - $2.83 Million
5,817 Added 1.31%
450,721 $171 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $4.19 Million - $5.04 Million
10,018 Added 2.3%
444,904 $213 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $2.72 Million - $3.52 Million
7,721 Added 1.81%
434,886 $183 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $5.09 Million - $6.95 Million
-12,347 Reduced 2.81%
427,165 $178 Million
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $180,831 - $232,892
390 Added 0.09%
439,512 $217 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $6.56 Million - $9.19 Million
12,499 Added 2.93%
439,122 $247 Million
Q4 2021

Feb 11, 2022

SELL
$708.84 - $794.68 $582,666 - $653,226
-822 Reduced 0.19%
426,623 $322 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $23.8 Million - $29.9 Million
36,170 Added 9.24%
427,445 $318 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $7.84 Million - $8.82 Million
13,591 Added 3.6%
391,275 $251 Million
Q1 2021

May 12, 2021

BUY
$547.01 - $662.35 $11.8 Million - $14.3 Million
21,546 Added 6.05%
377,684 $215 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $4.05 Million - $5.1 Million
7,926 Added 2.28%
356,138 $207 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $1.14 Million - $1.34 Million
2,498 Added 0.72%
348,212 $179 Million
Q2 2020

Aug 13, 2020

BUY
$334.87 - $493.06 $32.4 Million - $47.7 Million
96,777 Added 38.88%
345,714 $156 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $1.9 Million - $2.43 Million
5,951 Added 2.45%
248,937 $87.2 Million
Q4 2019

Feb 13, 2020

BUY
$319.73 - $374.2 $3.95 Million - $4.62 Million
12,340 Added 5.35%
242,986 $89.8 Million
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $4.47 Million - $5.06 Million
14,664 Added 6.79%
230,646 $76.7 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $2.24 Million - $2.45 Million
-7,822 Reduced 3.5%
215,982 $67.5 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $2.16 Million - $3.05 Million
9,616 Added 4.49%
223,804 $68.4 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $3.42 Million - $4.81 Million
15,557 Added 7.83%
214,188 $49.7 Million
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $3.96 Million - $4.46 Million
13,680 Added 7.4%
198,631 $62.2 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $2.01 Million - $2.51 Million
8,250 Added 4.67%
184,951 $53.4 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $795,498 - $931,974
-3,400 Reduced 1.89%
176,701 $44.2 Million
Q4 2017

Feb 13, 2018

BUY
$216.94 - $271.3 $1.26 Million - $1.58 Million
5,819 Added 3.34%
180,101 $43 Million
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $537,892 - $613,937
2,534 Added 1.48%
174,282 $38.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
171,748
171,748 $38.9 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.